SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-17-022648
Filing Date
2017-04-27
Accepted
2017-04-27 16:15:19
Documents
1
Group Members
ALAIN SCHREIBERJAY MOORINPROQUEST ASSOCIATES IV LLCPROQUEST FINANCIAL LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v465373_sc-13da.htm SC 13D/A 117655
  Complete submission text file 0001144204-17-022648.txt   119422
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Subject) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88022 | Film No.: 17789249
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2430 VANDERBILT BEACH ROAD #108 - 190 NAPLES FL 34109
Business Address 2430 VANDERBILT BEACH ROAD #108 - 190 NAPLES FL 34109 609-919-3567
ProQuest Investments IV, L.P. (Filed by) CIK: 0001431818 (see all company filings)

IRS No.: 205935001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A